453 related articles for article (PubMed ID: 34104087)
1. SARS-CoV-2 infection activates a subset of intrinsic pathways to inhibit type I interferons
Luo W; Huang L; Wang X; Ma Y; Xiao J; Song X; Liu P; Wang Y; Wang Y; Ren Z
Int J Med Sci; 2021; 18(12):2561-2569. PubMed ID: 34104087
[TBL] [Abstract][Full Text] [Related]
2. Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of IFN-mediated innate immune defenses.
Herder V; Dee K; Wojtus JK; Epifano I; Goldfarb D; Rozario C; Gu Q; Da Silva Filipe A; Nomikou K; Nichols J; Jarrett RF; Stevenson A; McFarlane S; Stewart ME; Szemiel AM; Pinto RM; Masdefiol Garriga A; Davis C; Allan J; Graham SV; Murcia PR; Boutell C
PLoS Biol; 2021 Dec; 19(12):e3001065. PubMed ID: 34932557
[TBL] [Abstract][Full Text] [Related]
3. Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV.
Bouayad A
Rev Med Virol; 2020 Nov; 30(6):1-9. PubMed ID: 32734714
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the SARS-CoV-2 Host Response in Primary Human Airway Epithelial Cells from Aged Individuals.
Subramaniyan B; Larabee JL; Bodas M; Moore AR; Burgett AWG; Myers DA; Georgescu C; Wren JD; Papin JF; Walters MS
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452468
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Comparison of RNA-Seq Data of SARS-CoV-2, SARS-CoV and MERS-CoV Infections: Alternative Entry Routes and Innate Immune Responses.
Cao Y; Xu X; Kitanovski S; Song L; Wang J; Hao P; Hoffmann D
Front Immunol; 2021; 12():656433. PubMed ID: 34122413
[TBL] [Abstract][Full Text] [Related]
6. Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response.
Vishnubalaji R; Shaath H; Alajez NM
Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32646047
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.
Chen H; Liu W; Wang Y; Liu D; Zhao L; Yu J
EBioMedicine; 2021 Aug; 70():103500. PubMed ID: 34311326
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 multifaceted interaction with the human host. Part II: Innate immunity response, immunopathology, and epigenetics.
Beacon TH; Su RC; Lakowski TM; Delcuve GP; Davie JR
IUBMB Life; 2020 Nov; 72(11):2331-2354. PubMed ID: 32936531
[TBL] [Abstract][Full Text] [Related]
9. Competitive Endogenous RNA Network Activates Host Immune Response in SARS-CoV-2-, panH1N1 (A/California/07/2009)-, and H7N9 (A/Shanghai/1/2013)-Infected Cells.
Yang M; Li J; Deng S; Fan H; Peng Y; Ye G; Wang J; Wei J; Jiang X; Xu Z; Qing L; Wang F; Yang Y; Liu Y
Cells; 2022 Jan; 11(3):. PubMed ID: 35159296
[TBL] [Abstract][Full Text] [Related]
10. Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection.
Schuhenn J; Meister TL; Todt D; Bracht T; Schork K; Billaud JN; Elsner C; Heinen N; Karakoese Z; Haid S; Kumar S; Brunotte L; Eisenacher M; Di Y; Lew J; Falzarano D; Chen J; Yuan Z; Pietschmann T; Wiegmann B; Uebner H; Taube C; Le-Trilling VTK; Trilling M; Krawczyk A; Ludwig S; Sitek B; Steinmann E; Dittmer U; Lavender KJ; Sutter K; Pfaender S
Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35131898
[TBL] [Abstract][Full Text] [Related]
11. An Update on Innate Immune Responses during SARS-CoV-2 Infection.
Zhang Y; Chen S; Jin Y; Ji W; Zhang W; Duan G
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696490
[TBL] [Abstract][Full Text] [Related]
12. Ribosome-Profiling Reveals Restricted Post Transcriptional Expression of Antiviral Cytokines and Transcription Factors during SARS-CoV-2 Infection.
Alexander MR; Brice AM; Jansen van Vuren P; Rootes CL; Tribolet L; Cowled C; Bean AGD; Stewart CR
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33806254
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO.
Wu J; Shi Y; Pan X; Wu S; Hou R; Zhang Y; Zhong T; Tang H; Du W; Wang L; Wo J; Mu J; Qiu Y; Yang K; Zhang LK; Ye BC; Qi N
Cell Rep; 2021 Feb; 34(7):108761. PubMed ID: 33567255
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of Antiviral Immune Evasion of SARS-CoV-2.
Beyer DK; Forero A
J Mol Biol; 2022 Mar; 434(6):167265. PubMed ID: 34562466
[TBL] [Abstract][Full Text] [Related]
15. Virus Caused Imbalance of Type I IFN Responses and Inflammation in COVID-19.
Zhang J; Zhao C; Zhao W
Front Immunol; 2021; 12():633769. PubMed ID: 33912161
[TBL] [Abstract][Full Text] [Related]
16. Type I and III interferon responses in SARS-CoV-2 infection.
Kim YM; Shin EC
Exp Mol Med; 2021 May; 53(5):750-760. PubMed ID: 33953323
[TBL] [Abstract][Full Text] [Related]
17. Elimination of Aicardi-Goutières syndrome protein SAMHD1 activates cellular innate immunity and suppresses SARS-CoV-2 replication.
Oo A; Zandi K; Shepard C; Bassit LC; Musall K; Goh SL; Cho YJ; Kim DH; Schinazi RF; Kim B
J Biol Chem; 2022 Mar; 298(3):101635. PubMed ID: 35085552
[TBL] [Abstract][Full Text] [Related]
18. Increased Sensitivity of SARS-CoV-2 to Type III Interferon in Human Intestinal Epithelial Cells.
Metz-Zumaran C; Kee C; Doldan P; Guo C; Stanifer ML; Boulant S
J Virol; 2022 Apr; 96(7):e0170521. PubMed ID: 35262371
[TBL] [Abstract][Full Text] [Related]
19. Sensing of cytoplasmic chromatin by cGAS activates innate immune response in SARS-CoV-2 infection.
Zhou Z; Zhang X; Lei X; Xiao X; Jiao T; Ma R; Dong X; Jiang Q; Wang W; Shi Y; Zheng T; Rao J; Xiang Z; Ren L; Deng T; Jiang Z; Dou Z; Wei W; Wang J
Signal Transduct Target Ther; 2021 Nov; 6(1):382. PubMed ID: 34732709
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2-mediated evasion strategies for antiviral interferon pathways.
Oh SJ; Shin OS
J Microbiol; 2022 Mar; 60(3):290-299. PubMed ID: 35122601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]